Skip to content
DeepViews

STERIS plc (STE) — Analysis Summary

STERIS plc (STE) has a market cap of $21.35B with year-over-year revenue growth of +8.7%. Net margin stands at 13.2%. The stock trades at a P/E ratio of 26.5.

Key Takeaways

  • Revenue changed +8.7% year-over-year
  • Net margin of 13.2%
  • P/E ratio of 26.5

Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, STE posted revenue growth of +8.7% and trades at a P/E of 26.5.

[XNYS]

STERIS plc (STE)

$218.98

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$21.35B
Enterprise Value
$22.76B
P/E Ratio
26.5
Div Yield
1.26%
EV/EBITDA
13.9
Company Profile
About
About STERIS plc

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

Sector

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Employees

17,937

Headquarters

DUBLIN, L2

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
63
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$7221.30M
Total Debt$1893.60M
Debt-to-Equity0.26
Cash & Equivalents$482.30M

Cash Flow

Operating Cash Flow$1288.50M
Free Cash Flow$925.60M
FCF Margin15.33%
P/FCF Ratio23.07
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$2.76

Dividend Yield

1.26%

Quarterly
Last Ex-Date: 2026-09-04

Dividend History

2026-09-04
CD$0.6900
2026-06-08
CD$0.6300
2026-02-17
CD$0.6300
2025-11-18
CD$0.6300
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.